huahaipharm(SH:600521) Xin Lang Cai Jing·2025-12-16 10:14Core Viewpoint - Huahai Pharmaceutical announced that the plaintiff in the Gaston Roberts personal injury compensation case has appealed the judgment that dismissed the lawsuit, with the company as the appellee. The amount involved in the appeal has not been specified. The appeal process has just begun and is in its early stages, making it difficult for the company to assess the impact on its financial results, which will depend on subsequent court rulings or enforcement outcomes. Aside from this case, there are no significant developments in other valsartan lawsuits in the U.S., and the outcomes remain uncertain [1]. Group 1 - The plaintiff in the Gaston Roberts case has appealed the dismissal of the lawsuit [1] - The company is currently unable to determine the financial impact of the appeal [1] - There are no significant updates on other valsartan lawsuits in the U.S. [1]